{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:21:45Z","timestamp":1761574905900,"version":"build-2065373602"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10815-025-03605-3","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:18:21Z","timestamp":1754061501000},"page":"2929-2936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mid-pregnancy circulating placental growth factor (PlGF) and obstetrical outcomes following nonovulatory and ovulatory frozen embryo transfer cycles"],"prefix":"10.1007","volume":"42","author":[{"given":"Trish","family":"Dinh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nichole","family":"Sanchez Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Kingdom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen M.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Drewlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7128-8916","authenticated-orcid":false,"given":"John W.","family":"Snelgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"4","key":"3605_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.fertnstert.2022.08.003","volume":"118","author":"A Chada","year":"2022","unstructured":"Chada A, Hipp HS. \u2018Let\u2019rozole it grow: endometrial preparation methods for frozen-thawed embryo transfer. Fertil Steril. 2022;118(4):699\u2013700.","journal-title":"Fertil Steril"},{"issue":"2","key":"3605_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.fertnstert.2019.12.008","volume":"113","author":"RF Casper","year":"2020","unstructured":"Casper RF. Frozen embryo transfer: evidence-based markers for successful endometrial preparation. Fertil Steril. 2020;113(2):248\u201351.","journal-title":"Fertil Steril"},{"key":"3605_CR3","doi-asserted-by":"crossref","unstructured":"Glujovsky D, Pesce R, Sueldo C, Quinteiro Retamar AM, Hart RJ, Ciapponi A. 2020 Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev. 10(10):Cd006359","DOI":"10.1002\/14651858.CD006359.pub3"},{"key":"3605_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmad011","author":"TR Zaat","year":"2023","unstructured":"Zaat TR, Kostova EB, Korsen P, Showell MG, Mol F, van Wely M. Obstetric and neonatal outcomes after natural versus artificial cycle frozen embryo transfer and the role of luteal phase support: a systematic review and meta-analysis. Hum Reprod Update. 2023. https:\/\/doi.org\/10.1093\/humupd\/dmad011.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"3605_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.fertnstert.2022.07.025","volume":"118","author":"P Bortoletto","year":"2022","unstructured":"Bortoletto P, Prabhu M, Baker VL. Association between programmed frozen embryo transfer and hypertensive disorders of pregnancy. Fertil Steril. 2022;118(5):839\u201348.","journal-title":"Fertil Steril"},{"issue":"4","key":"3605_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.fertnstert.2020.10.039","volume":"115","author":"LL Asserh\u00f8j","year":"2021","unstructured":"Asserh\u00f8j LL, Spangmose AL, Aaris Henningsen AK, Clausen TD, Ziebe S, Jensen RB, et al. Adverse obstetric and perinatal outcomes in 1,136 singleton pregnancies conceived after programmed frozen embryo transfer (FET) compared with natural cycle FET. Fertil Steril. 2021;115(4):947\u201356.","journal-title":"Fertil Steril"},{"issue":"4","key":"3605_CR7","doi-asserted-by":"publisher","first-page":"e677","DOI":"10.1152\/ajpendo.00225.2019","volume":"317","author":"KP Conrad","year":"2019","unstructured":"Conrad KP, Graham GM, Chi YY, Zhai X, Li M, Williams RS, et al. Potential influence of the corpus luteum on circulating reproductive and volume regulatory hormones, angiogenic and immunoregulatory factors in pregnant women. Am J Physiol Endocrinol Metab. 2019;317(4):e677\u201385.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"3605_CR8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/1471-0528.17837","volume":"131","author":"RL Zur","year":"2024","unstructured":"Zur RL, McLaughlin K, Aalto L, Jiang Y, Huszti E, Parks WT, et al. Phenotypes of maternal vascular malperfusion placental pathology and adverse pregnancy outcomes: a retrospective cohort study. BJOG An Int J Obstet Gynaecol. 2024;131(11):1515\u201323.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"2","key":"3605_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/ijms23020659","volume":"23","author":"C Manna","year":"2022","unstructured":"Manna C, Lacconi V, Rizzo G, De Lorenzo A, Massimiani M. Placental dysfunction in assisted reproductive pregnancies: perinatal, neonatal and adult life outcomes. Int J Mol Sci. 2022;23(2):659.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3605_CR10","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1161\/HYPERTENSIONAHA.121.17047","volume":"77","author":"K McLaughlin","year":"2021","unstructured":"McLaughlin K, Snelgrove JW, Audette MC, Syed A, Hobson SR, Windrim RC, et al. PlGF (Placental Growth Factor) testing in clinical practice: evidence from a Canadian tertiary maternity referral center. Hypertension. 2021;77(6):2057\u201365.","journal-title":"Hypertension"},{"issue":"11","key":"3605_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.44454","volume":"7","author":"RA Gladstone","year":"2024","unstructured":"Gladstone RA, Ahmed S, Huszti E, McLaughlin K, Snelgrove JW, Taher J, et al. Midpregnancy placental growth factor screening and early preterm birth. JAMA Netw Open. 2024;7(11): e2444454.","journal-title":"JAMA Netw Open"},{"key":"3605_CR12","doi-asserted-by":"crossref","unstructured":"Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, Matallana CdP, et al. 2017 Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. New England Journal of Medicine. 377(7):613\u201322","DOI":"10.1056\/NEJMoa1704559"},{"key":"3605_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.preghy.2021.05.023","volume":"25","author":"S Shinar","year":"2021","unstructured":"Shinar S, Tigert M, Agrawal S, Parks WA, kingdom JC. Placental growth factor as a diagnostic tool for placental mediated fetal growth restriction. Pregnancy Hypertens. 2021;25:123\u20138.","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"3605_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstr\u00f6m M, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13\u201322.","journal-title":"N Engl J Med"},{"issue":"6","key":"3605_CR15","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1067\/mob.2001.113129","volume":"184","author":"SC Tidwell","year":"2001","unstructured":"Tidwell SC, Ho H-N, Chiu W-H, Torry RJ, Torry DS. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol. 2001;184(6):1267\u201372.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"3605_CR16","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1210\/jc.2003-031244","volume":"89","author":"R Thadhani","year":"2004","unstructured":"Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab. 2004;89(2):770\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"3605_CR17","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","volume":"128","author":"LC Chappell","year":"2013","unstructured":"Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia. Circulation. 2013;128(19):2121\u201331.","journal-title":"Circulation"},{"issue":"10","key":"3605_CR18","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/1471-0528.12195","volume":"120","author":"JE Myers","year":"2013","unstructured":"Myers JE, Kenny LC, McCowan LM, Chan EH, Dekker GA, Poston L, et al. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG. 2013;120(10):1215\u201323.","journal-title":"BJOG"},{"issue":"3","key":"3605_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1161\/HYPERTENSIONAHA.114.03578","volume":"64","author":"LC Kenny","year":"2014","unstructured":"Kenny LC, Black MA, Poston L, Taylor R, Myers JE, Baker PN, et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the screening for pregnancy endpoints (SCOPE) international cohort study. Hypertension. 2014;64(3):644\u201352.","journal-title":"Hypertension"},{"issue":"12","key":"3605_CR20","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s10815-017-1023-2","volume":"34","author":"I Woo","year":"2017","unstructured":"Woo I, Chan Y, Sriprasert I, Louie K, Ingles S, Stanczyk F, et al. The role of angiogenic markers in adverse perinatal outcomes: fresh versus frozen embryo transfers. J Assist Reprod Genet. 2017;34(12):1639\u201343.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"3605_CR21","doi-asserted-by":"publisher","first-page":"212.e1","DOI":"10.1016\/j.ajog.2015.03.032","volume":"213","author":"MS Lee","year":"2015","unstructured":"Lee MS, Cantonwine D, Little SE, McElrath TF, Parry SI, Lim KH, et al. Angiogenic markers in pregnancies conceived through in vitro fertilization. Am J Obstet Gynecol. 2015;213(2):212.e1-8.","journal-title":"Am J Obstet Gynecol"},{"key":"3605_CR22","doi-asserted-by":"crossref","unstructured":"Magee LA, Smith GN, Bloch C, Cote AM, Jain V, Nerenberg K, von Dadelszen P, Helewa M, Rey E. Guideline no. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management. Journal of Obstetrics and Gynaecology Canada. 2022;44(5):547\u201371 e1.","DOI":"10.1016\/j.jogc.2022.03.002"},{"key":"3605_CR23","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.1016\/j.jcjd.2017.10.038","volume":"42","author":"DS Feig","year":"2018","unstructured":"Feig DS, Berger H, Donovan L, Godbout A, Kader T, Keely E, et al. Diabetes and pregnancy. Can J Diabetes. 2018;42:S255\u201382.","journal-title":"Can J Diabetes"},{"key":"3605_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.mce.2018.08.003","volume":"478","author":"JS Beltrame","year":"2018","unstructured":"Beltrame JS, Sordelli MS, Ca\u00f1umil VA, Alonso CAI, Perez Martinez S, Ribeiro ML. Steroid hormones induce in vitro human first trimester trophoblast tubulogenesis by the lysophosphatidic acid pathway. Mol Cell Endocrinol. 2018;478:126\u201332.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"3605_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/humupd\/dmw004","volume":"22","author":"F Schatz","year":"2016","unstructured":"Schatz F, Guzeloglu-Kayisli O, Arlier S, Kayisli UA, Lockwood CJ. The role of decidual cells in uterine hemostasis menstruation inflammation adverse pregnancy outcomes and abnormal uterine bleeding. Hum Reprod Update. 2016;22(4):497\u2013515.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"3605_CR26","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/HYPERTENSIONAHA.119.13015","volume":"74","author":"KP Conrad","year":"2019","unstructured":"Conrad KP, Petersen JW, Chi YY, Zhai X, Li M, Chiu KH, et al. Maternal cardiovascular dysregulation during early pregnancy after in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. 2019;74(3):705\u201315.","journal-title":"Hypertension"},{"issue":"7","key":"3605_CR27","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s10815-019-01484-z","volume":"36","author":"M Relji\u010d","year":"2019","unstructured":"Relji\u010d M, Porovi\u0107 A. Maternal serum levels of angiogenic markers and markers of placentation in pregnancies conceived with fresh and vitrified-warmed blastocyst transfer. J Assist Reprod Genet. 2019;36(7):1489\u201395.","journal-title":"J Assist Reprod Genet"},{"issue":"10","key":"3605_CR28","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1007\/s10815-024-03193-8","volume":"41","author":"JW Snelgrove","year":"2024","unstructured":"Snelgrove JW, Lee R, Jeyakumar Y, Greenblatt EM, Kingdom JC, Zwingerman R, et al. Maternal placental growth factor (PlGF) levels, sonographic placental parameters, and outcomes of IVF pregnancies with and without embryo trophectoderm biopsy. J Assist Reprod Genet. 2024;41(10):2721\u20136.","journal-title":"J Assist Reprod Genet"},{"key":"3605_CR29","doi-asserted-by":"crossref","unstructured":"Barton JR, Woelkers DA, Newman RB, Combs CA, How HY, Boggess KA, et al. 2020 Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study. American Journal of Obstetrics & Gynecology. 222(3):259.e1-.e11","DOI":"10.1016\/j.ajog.2019.09.003"},{"key":"3605_CR30","unstructured":"Placental growth factor (PlGF)- based biomarker testing to help diagnose pre-eclampsia in people with suspected pre-eclampsia: a health technology assessment. Ont Health Technol Assess Ser. 2023 23(3):1\u2013146"},{"issue":"26","key":"3605_CR31","doi-asserted-by":"publisher","first-page":"E897","DOI":"10.1503\/cmaj.231547","volume":"196","author":"S Dzakpasu","year":"2024","unstructured":"Dzakpasu S, Nelson C, Darling EK, Edwards W, Murphy PA, Scott H, et al. Trends in rate of hypertensive disorders of pregnancy and associated morbidities in Canada: a population-based study (2012\u20132021). CMAJ. 2024;196(26):E897-e904.","journal-title":"CMAJ"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03605-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-025-03605-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03605-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:16:55Z","timestamp":1761571015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-025-03605-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3605"],"URL":"https:\/\/doi.org\/10.1007\/s10815-025-03605-3","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"type":"print","value":"1058-0468"},{"type":"electronic","value":"1573-7330"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional research ethics board approval was obtained for this study (REB\u00a0#20\u20130086-E-E).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"KM, JCK, and JWS have received research grant funding from Roche Diagnostics. TD, NSD, EMG, and SD declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}